Formosa Pharmaceuticals has announced the first shipment of clobetasol propionate ophthalmic suspension 0.05% (APP13007) to ...

September is Leukemia and Lymphoma Awareness Month. An estimated 1,629,474 people in the United States (US) are living with or in remission from leukemia, lymphoma, myeloma, myelodysplastic ...

NICE has recommended belzutifan for some adults with Von Hippel-Lindau disease, in final draft guidance, which could benefit up to 100 people. Looking back over the journey from our humble beginnings ...

Primary non-Hodgkin's lymphoma of the breast (PBNHL) is uncommon. There have been only a few reports of breast lymphoma in the radiology literature. In this case report, we describe mammographic ...

The following is a summary of “Systemic and ocular outcomes in TB-immunoreactive patients receiving immunomodulatory therapy for non-infectious uveitis: a case-control study,” published in the July ...

Bullock, who was diagnosed with diffuse large B-cell non-Hodgkin lymphoma in the fall of 2016, said a steady supply is crucial for many people, including those with other cancers and sickle cell ...

In winning European approval, Ordspono became Regeneron’s first “bispecific” antibody drug, a class that has been in the spotlight in recent years as an alternative to costly and cumbersome CAR-T cell ...